Medical Devices News and Research

RSS
Positive pre-clinical study data of Lamellar Biomedical's Visco-ease published in Supportive Care Journal

Positive pre-clinical study data of Lamellar Biomedical's Visco-ease published in Supportive Care Journal

AstraZeneca’s TAGRISSO (osimertinib) approved in EU for metastatic EGFR T790M mutation-positive NSCLC

AstraZeneca’s TAGRISSO (osimertinib) approved in EU for metastatic EGFR T790M mutation-positive NSCLC

NJHF awards 30 grants for NJ researchers working on health-related research

NJHF awards 30 grants for NJ researchers working on health-related research

Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

Asian manufacturers wear testing offered by Lucideon & Hong Kong standards and testing center collaboration

Asian manufacturers wear testing offered by Lucideon & Hong Kong standards and testing center collaboration

Edwards Lifesciences' global sales grow 8.6% to $671.1 million in fourth quarter 2015

Edwards Lifesciences' global sales grow 8.6% to $671.1 million in fourth quarter 2015

AccuTEC Blades introduces GEM RUNNER Reloadable Safety Single-Edge Blade Dispenser

AccuTEC Blades introduces GEM RUNNER Reloadable Safety Single-Edge Blade Dispenser

Three RIT students awarded top honors for research on bio-separation techniques

Three RIT students awarded top honors for research on bio-separation techniques

Using centrifugal elutriation and flow cytometry to answer biological questions: an interview with Peter Lopez

Using centrifugal elutriation and flow cytometry to answer biological questions: an interview with Peter Lopez

Panasonic introduces new -40°C freezer with hydrocarbon refrigerant

Panasonic introduces new -40°C freezer with hydrocarbon refrigerant

BioLineRx's BL-7010 confirmed as Class IIb medical device in European Union

BioLineRx's BL-7010 confirmed as Class IIb medical device in European Union

Carbapenem-resistant Enterobacteriaceae: an interview with Dr. Michael Dudley

Carbapenem-resistant Enterobacteriaceae: an interview with Dr. Michael Dudley

Biomedical innovation in the UK: an interview with Zahid Latif

Biomedical innovation in the UK: an interview with Zahid Latif

Singularity University, BD establish collaborative relationship to tackle global healthcare challenges

Singularity University, BD establish collaborative relationship to tackle global healthcare challenges

UM SOM selected to work with BARDA to develop radiologic and nuclear countermeasures

UM SOM selected to work with BARDA to develop radiologic and nuclear countermeasures

FDA issues draft guidance to address cybersecurity vulnerabilities in medical devices

FDA issues draft guidance to address cybersecurity vulnerabilities in medical devices

OptMed obtains FDA 510(k) marketing clearance for topical skin adhesive

OptMed obtains FDA 510(k) marketing clearance for topical skin adhesive

Occlutech's Atrial Septal Defect Closure Device approved in Japan

Occlutech's Atrial Septal Defect Closure Device approved in Japan

NeuroSky develops cost-effective, secure medical monitoring solution to improve remote patient care

NeuroSky develops cost-effective, secure medical monitoring solution to improve remote patient care

JJHWS, Plug and Play Tech Center partner to support companies developing wellness solutions

JJHWS, Plug and Play Tech Center partner to support companies developing wellness solutions

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.